BioMelbourne News

Australia is backing health innovation industries to build future economy

Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…

New BioMelbourne Network Board Appointment – David Herd

The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting.  “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…

BioMelbourne Network gives State Budget 6/10 for the health innovation industry

BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…

New report aims to broaden understanding of how new medicines are funded in Australia

– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…

2017 – A Big Year for Biotech!

Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…

BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System

October 2017 “Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies…

Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria

September 2017 Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture…

Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics

We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…

Ask Industry Anything (Again) – Tuesday 28th November 2017

BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…

BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017

With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…

Joint Statement on Skilled Migration Visa Changes

July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…

Home

News & opinion

Member Directory

Events